Hint mode is switched on Switch off
For swift navigation between sections

Viela Bio

Organization name
Viela Bio, Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Viela Bio, Inc. operates as a clinical-stage biotechnology company. The Company develops and commercializes therapeutics and medicines for the treatment of patients with autoimmune and severe inflammatory diseases. Viela Bio serves patients worldwide.

Awards

Documentation

IFRS/US GAAP reports

2020
2019
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001734517
Registration is required to get access.